Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2002-09-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1062-1458(02)01016-4PMID 12243636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High risk of cerebro-cardiovascular morbidity in well treated male hypertensives. A retrospective study of 40-59-year-old hypertensives in a Swedish primary care district.

  2009cited by this paper
• Applied Logistic Regression

  2002cited by this paper
• Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

  2002cited by this paper
• Stroke is More Common than Myocardial Infarction in Hypertension: Analysis based on 11 Major Randomized Intervention Trials

  2001cited by this paper
• Left Ventricular Hypertrophy as an Independent Predictor of Acute Cerebrovascular Events in Essential Hypertension

  2001cited by this paper
• Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease.

  2001cited by this paper
• Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

  2000cited by this paper
• Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study.

  2000cited by this paper
• Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.

  2000cited by this paper
• Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.

  2000cited by this paper
• Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics.

  1999cited by this paper
• Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

  1998cited by this paper
• Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension

  1998cited by this paper
• Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?: A Systematic Review

  1998cited by this paper
• Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review.

  1998cited by this paper
• The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.

  1997cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension *

  1997cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

  1997cited by this paper
• Estimating Causal Effects from Large Data Sets Using Propensity Scores

  1997cited by this paper
• Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials

  1996cited by this paper
• Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity.

  1996cited by this paper
• Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach.

  1995cited by this paper
• Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.

  1995cited by this paper
• Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment

  1995cited by this paper
• Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products.

  1995cited by this paper
• Improved electrocardiographic diagnosis of left ventricular hypertrophy.

  1994cited by this paper
• Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy.

  1994cited by this paper
• Diabetes mellitus.

  1993cited by this paper
• Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies.

  1992cited by this paper
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

  1991cited by this paper
• An updated coronary risk profile. A statement for health professionals.

  1991cited by this paper
• Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1

  1987cited by this paper
• Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings.

  1987cited by this paper
• Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Göteborg, Sweden.

  1987cited by this paper
• Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.

  1986cited by this paper
• Mortality in patients of the Glasgow Blood Pressure Clinic.

  1986cited by this paper
• Systolic Hypertension in the Elderly Program (SHEP)

  1986cited by this paper
• Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study.

  1981cited by this paper
• Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.

  1981cited by this paper
• Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study.

  1971cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Mechanisms to medicines: navigating drug repurposing strategies in Alzheimer’s disease

  2026cites this paper
• Simultaneous determination of triamterene and losartan mixture in spiked human plasma utilizing high-performance thin-layer chromatography with ultraviolet detection

  2025cites this paper
• Dual pH-optimized HPTLC method for simultaneous quantification and enhanced fluorescence detection of triamterene and losartan in human plasma: Toward achieving maximum separate fluorescence intensity

  2025cites this paper
• Changes of electrocardiography in clinical outcomes of chronic kidney disease: a retrospective study

  2023cites this paper
• β blockers switched to first-line therapy in hypertension.

  2023cites this paper
• Superior stroke prevention with angiotensin receptor blockers compared with other antihypertensive drugs

  2023cites this paper
• Features of the treatment of arterial hypertension in elderly patients

  2023cites this paper
• Incremental prognostic value of positron emission tomography derived left ventricular mass

  2022cites this paper
• Emerging therapeutic targets for cardiac hypertrophy

  2022cites this paper
• Incident left bundle branch block predicts cardiovascular events and death in hypertensive patients with left ventricular hypertrophy. The LIFE Study

  2022cites this paper
• Development of systolic dysfunction unrelated to myocardial infarction in treated hypertensive patients with left ventricular hypertrophy. The LIFE Study

  2022cites this paper
• Determination of sources of error and improvement in accuracy of left ventricular mass measurement by echocardiography

  2022cites this paper
• Incident atrial fibrillation and heart failure in treated hypertensive patients with left ventricular hypertrophy. The LIFE Study

  2022cites this paper
• Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction

  2021cites this paper
• A Point System Table to Estimate the Risk of Cardiovascular Events in Patients with Hypertension and Left Ventricular Hypertrophy: The LIFE Study

  2021cites this paper
• Assessment of Nonfatal Myocardial Infarction as a Surrogate for All-Cause and Cardiovascular Mortality in Treatment or Prevention of Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials.

  2021cites this paper
• O enorme custo da obesidade para a saúde pública brasileira: Uma breve revisão de literatura

  2021cites this paper
• Die Behandlung der arteriellen Hypertonie mit Angiotensin-Rezeptorblockern

  2020cites this paper
• Hypertension in the Dog and Cat

  2020cites this paper
• Serum uric acid and left ventricular hypertrophy in hypertensive patients in Ado-Ekiti

  2020cites this paper
• Treatment strategies for isolated systolic hypertension in elderly patients

  2020cites this paper
• Hypertension and the Heart and Vasculature

  2020cites this paper
• Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries.

  2020cites this paper
• Endothelial cell modulation of cardiomyocyte gene expression.

  2019cites this paper
• Le diabète chez les personnes âgées Comité d’experts des Lignes directrices de pratique clinique de Diabète Canada

  2019cites this paper
• Cardiovascular Disease in Older Adults

  2019cites this paper
• Die Behandlung der arteriellen Hypertonie mit Angiotensin-Rezeptorblockern

  2019influential citation
• miR-154-5p Functions as an Important Regulator of Angiotensin II-Mediated Heart Remodeling

  2019cites this paper
• Linksventrikuläre Hypertrophie und arterielle Hypertonie im Praxisalltag-Das LIIFE-in-LIFE-Projekt

  2019cites this paper
• Antihypertensive therapy prevents new-onset atrial fibrillation in patients with isolated systolic hypertension: the LIFE study

  2019cites this paper
• Comparison of real-world effectiveness between valsartan and non-RAS inhibitor monotherapy on the incidence of new diabetes in Chinese hypertensive patients: An electronic health recording system based study

  2019cites this paper
• Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network).

  2018cites this paper
• Clinical outcomes in hypertensive patients treated with a single‐pill fixed‐dose combination of renin‐angiotensin system inhibitor and thiazide diuretic

  2018cites this paper
• Isoliert systolische Hypertonie beim älteren Menschen

  2018cites this paper
• Egg White Ovotransferrin‐Derived ACE Inhibitory Peptide Ameliorates Angiotensin II‐Stimulated Insulin Resistance in Skeletal Muscle Cells

  2018cites this paper
• Isoliert systolische Hypertonie beim älteren Menschen

  2018cites this paper
• Long‐term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial

  2018cites this paper
• Isolated Systolic Hypertension: In the Young and in the Elderly

  2018cites this paper
• Racial/ethnic differences in the prognostic utility of left ventricular mass index for incident cardiovascular disease

  2018cites this paper
• Arterial hypertension after age 65: from epidemiology and pathophysiology to therapy Do we know where we stand?

  2018cites this paper
• Diabetes in Older People.

  2018cites this paper
• Electrocardiographic changes before and after successful kidney transplantation and associations with cardiovascular and mortality outcomes

  2018cites this paper
• Die Behandlung der arteriellen Hypertonie mit Angiotensin-Rezeptorblockern

  2018influential citation
• Atherosclerosis impacts the link between hepatocyte growth factor and cognition

  2018cites this paper
• Uric Acid and Left Ventricular Hypertrophy: A Potentially New Modifiable Target?

  2017cites this paper
• Beta‐Blocker Use Is Associated With Impaired Left Atrial Function in Hypertension

  2017cites this paper
• ±Association of Oxidative Stress, Serum Nitric Oxide, Plasma Fibrinogen in Hypertensive Males of Southern odisha

  2017cites this paper
• Prognostic Impact of Mild Hypokalemia in Terms of Death and Stroke in the General Population-A Prospective Population Study.

  2017cites this paper
• Left Ventricular Measurements in Black Sub-Saharan Africans and White Maghreb

  2017cites this paper
• Isolated Systolic Hypertension: An Update After SPRINT.

  2016cites this paper
• [Comparison of treatment principles of elderly hypertensive patients with different cardiovascular risks based on Hungarian and international guidelines (2001-2015)].

  2016cites this paper
• [From risk charts to guidelines: tools for evaluation and management of cardiovascular risk].

  2016cites this paper
• Hypertension and stroke: an appraisal of the evidence and implications for clinical management

  2016cites this paper
• Angiotensin II Type 1 receptor (AGTR1) gene polymorphisms are associated with vascular manifestations in patients with systemic sclerosis (SSc)

  2016cites this paper
• MANAGEMENT OF BLOOD PRESSURE CONTROL: AT THE CUTTING EDGE

  2016cites this paper
• Angiotensin Inhibitors Potentiate the Hypoglycemic and Antioxidant Effects of Gliclazide in Rats

  2015cites this paper
• Is Inhibition of Hypertrophy a Good Therapeutic Strategy in Ventricular Pressure Overload? Inhibition of Hypertrophy Is a Good Therapeutic Strategy in Ventricular Pressure Overload C ONTROvERSIES IN C ARDIOvASCUlAR M EDICINE

  2015cites this paper
• Targeting Central Blood Pressure Through the Macro- and Microcirculation Cross-Talk

  2015cites this paper
• Management of Blood Pressure Control: At the Cutting Edge

  2015cites this paper
• Research Article Ambulatory 24-hour cardiac oxygen consumption and blood pressure-heart rate variability: effects of nebivolol and valsartan alone and in combination

  2015cites this paper
• Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).

  2015cites this paper
• Angiotensin Receptor Blockade Modulates NFκB and STAT3 Signaling and Inhibits Glial Activation and Neuroinflammation Better than Angiotensin-Converting Enzyme Inhibition

  2015cites this paper
• Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association.

  2015cites this paper
• Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload.

  2015cites this paper
• Combination therapy in chronic kidney disease?

  2015cites this paper
• Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer

  2015cites this paper
• Liver X receptors in cardiac hypertrophy

  2015cites this paper
• Inflammation in Heart Failure with Preserved Ejection Fraction

  2015cites this paper
• Ambulatory 24-hour cardiac oxygen consumption and blood pressure-heart rate variability: effects of nebivolol and valsartan alone and in combination.

  2015cites this paper
• Резистентна артеріальна гіпертензія: пошук оптимальної комбінованої терапії

  2015cites this paper
• Early and sustained blood pressure control is necessary for stroke prevention.

  2015cites this paper
• Hipertensión arterial sistólica aislada en personas de edad avanzada: Revisión sistemática sobre las recomendaciones para su manejo terapéutico

  2015cites this paper
• Role of Nuclear Angiotensin-II Receptor Mediated Signalling in Cardiovascular Remodelling

  2015cites this paper
• Investigations into the role of the ErbB4 receptor in cardiomyocyte hypertrophy and adult cardiac function

  2015cites this paper
• Pharmacoepidemiology of antagonist receptors of the angiotensin (ARA) II in the treatment of essential hypertension. Mexico

  2014cites this paper
• AT1 blockade abolishes left ventricular hypertrophy in heterozygous cMyBP‐C null mice: role of FHL1

  2014cites this paper
• Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice

  2014cites this paper
• Factors Influencing the Decline in Stroke Mortality: A Statement From the American Heart Association/American Stroke Association

  2014cites this paper
• [The effect of angiotensin receptor blockers in cerebrovascular disorders and dementia: bonus in addition to the antihypertensive effect].

  2014cites this paper
• Value of electrocardiogram in predialytic chronic kidney disease patient without known coronary artery disease

  2014cites this paper
• Telmisartan reduces mortality and left ventricular hypertrophy with sympathoinhibition in rats with hypertension and heart failure.

  2014cites this paper
• ADMA metabolism and chronic hypoxia-induced pulmonary hypertenstion

  2014cites this paper
• Management and Care of Older Cardiac Patients

  2014cites this paper
• Antihypertensive Medication Exposure and Cardiovascular Outcomes in Hemodialysis Patients

  2014cites this paper
• Drug Safety and Effectiveness Network Report: A Systematic Review with Network Meta-Analyses and Economic Evaluation Comparing Therapies for Hypertension in Non-Diabetic Patients

  2014cites this paper
• Left-ventricular hypertrophy is associated better with 24-h aortic pressure than 24-h brachial pressure in hypertensive patients: the SAFAR study

  2014cites this paper
• Guidelines for the management of arterial hypertension

  2014cites this paper
• Hypertensive subjects with type-2 diabetes, the sympathetic nervous system, and treatment implications.

  2014cites this paper
• Discovery of Novel GPVI Receptor Antagonists by Structure-Based Repurposing

  2014cites this paper
• Pharmacological management of hypertension in the elderly--certitudes and controversies.

  2014cites this paper
• Blood Pressure and Cholesterol Control in Hypertensive Hypercholesterolemic Patients: National Health and Nutrition Examination Surveys 1988–2010

  2013cites this paper
• The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans

  2013cites this paper
• Direct renin inhibition: extricating facts from façades

  2013cites this paper
• ARB and Cardioprotection

  2013cites this paper
• Results of a 14-Week, Multicenter, Prospective, Randomized, Open-Label, Noninferiority Clinical Trial Comparing the Antihypertensive Effect and Edema Incidence of Lacidipine and Amlodipine in Older Korean Patients with Mild-to-Moderate Hypertension

  2013cites this paper
• A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol

  2013cites this paper
• Antagonistas de los receptores de la angiotensina II en el tratamiento de la hipertensión arterial, las enfermedades cardiovasculares y las renales. Realidad y futuro

  2013cites this paper
• Identification of the role of plasma membrane calcium ATPase isoform 4 (PMCA4) in modulating cardiac hypertrophy using a novel small molecule inhibitor

  2013cites this paper
• Impact of race on cumulative exposure to antihypertensive medications in dialysis.

  2013cites this paper
• Le diabète chez les personnes âgées

  2013cites this paper